Vanguard Group Inc Lexaria Bioscience Corp. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 133,554 shares of LEXX stock, worth $112,185. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133,554
Previous 127,871
4.44%
Holding current value
$112,185
Previous $218,000
46.79%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding LEXX
# of Institutions
23Shares Held
2.34MCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ1.17MShares$978,72025.66% of portfolio
-
Invenomic Capital Management LP Boston, MA501KShares$421,2330.03% of portfolio
-
Geode Capital Management, LLC Boston, MA175KShares$146,8140.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6133KShares$111,8250.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL44.9KShares$37,7160.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $5M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...